Skip to main content

Biden’s Racist First Year

The Liberty Loft

New guidance from Biden’s Food and Drug Administration instructs states to reserve monoclonal antibody drugs for patients with medical risk factors such as obesity and kidney disease. But here’s the catch: The FDA is also urging race and ethnicity to be considered risk factors, apart from medical condition. So a Black patient with no health problems automatically will be put ahead of a white patient in the same situation.